{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:41:46Z","timestamp":1792456906255,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,6,28]],"date-time":"2011-06-28T00:00:00Z","timestamp":1309219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s10495-011-0625-x","type":"journal-article","created":{"date-parts":[[2011,6,27]],"date-time":"2011-06-27T20:30:05Z","timestamp":1309206605000},"page":"1014-1027","source":"Crossref","is-referenced-by-count":136,"title":["Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2"],"prefix":"10.1007","volume":"16","author":[{"given":"Eleonore","family":"Mayola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Gallerne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide Degli","family":"Esposti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Martel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazib","family":"Pervaiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Larue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Debuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Lemaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,28]]},"reference":[{"key":"625_CR1","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4065\/82.4.490","volume":"82","author":"SN Markovic","year":"2007","unstructured":"Markovic SN, Erickson LA, Rao RD et al (2007) Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin Proc 82:490\u2013513","journal-title":"Mayo Clin Proc"},{"key":"625_CR2","first-page":"488","volume":"23","author":"S Bhatia","year":"2009","unstructured":"Bhatia S, Tykodi SS, Thompson JA (2009) Treatment of metastatic melanoma: an overview. Oncology (Williston Park) 23:488\u2013496","journal-title":"Oncology (Williston Park)"},{"key":"625_CR3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1600-0625.2007.00673.x","volume":"17","author":"P Lorigan","year":"2008","unstructured":"Lorigan P, Eisen T, Hauschild A (2008) Systemic therapy for metastatic malignant melanoma\u2014from deeply disappointing to bright future? Exp Dermatol 17:383\u2013394","journal-title":"Exp Dermatol"},{"key":"625_CR4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/138920208785699571","volume":"9","author":"J Eberle","year":"2008","unstructured":"Eberle J, Hossini AM (2008) Expression and function of bcl-2 proteins in melanoma. Curr Genom 9:409\u2013419","journal-title":"Curr Genom"},{"key":"625_CR5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.0022-202x.2001.01409.x","volume":"117","author":"M Raisova","year":"2001","unstructured":"Raisova M, Hossini AM, Eberle J et al (2001) The Bax\/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95\/Fas-mediated apoptosis. J Invest Dermatol 117:333\u2013340","journal-title":"J Invest Dermatol"},{"key":"625_CR6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57\u201370","journal-title":"Cell"},{"key":"625_CR7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd726","volume":"1","author":"JC Reed","year":"2002","unstructured":"Reed JC (2002) Apoptosis-based therapies. Nat Rev Drug Discov 1:111\u2013121","journal-title":"Nat Rev Drug Discov"},{"key":"625_CR8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd3137","volume":"9","author":"S Fulda","year":"2010","unstructured":"Fulda S, Galluzzi L, Kroemer G (2010) Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 9:447\u2013464","journal-title":"Nat Rev Drug Discov"},{"key":"625_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cdd.2008.150","volume":"16","author":"G Kroemer","year":"2009","unstructured":"Kroemer G, Galluzzi L, Vandenabeele P et al (2009) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16:3\u201311","journal-title":"Cell Death Differ"},{"key":"625_CR10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1152\/physrev.00013.2006","volume":"87","author":"G Kroemer","year":"2007","unstructured":"Kroemer G, Galluzzi L, Brenner C (2007) Mitochondrial membrane permeabilization in cell death. Physiol Rev 87:99\u2013163","journal-title":"Physiol Rev"},{"key":"625_CR11","doi-asserted-by":"crossref","first-page":"20327","DOI":"10.1073\/pnas.0808036105","volume":"105","author":"JE Chipuk","year":"2008","unstructured":"Chipuk JE, Fisher JC, Dillon CP, Kriwacki RW, Kuwana T, Green DR (2008) Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins. Proc Natl Acad Sci USA 105:20327\u201320332","journal-title":"Proc Natl Acad Sci USA"},{"key":"625_CR12","first-page":"205","volume":"20","author":"M Le Bras","year":"2005","unstructured":"Le Bras M, Clement MV, Pervaiz S, Brenner C (2005) Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol Histopathol 20:205\u2013219","journal-title":"Histol Histopathol"},{"key":"625_CR13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1158\/1078-0432.CCR-06-2082","volume":"13","author":"JP Fruehauf","year":"2007","unstructured":"Fruehauf JP, Meyskens FL Jr (2007) Reactive oxygen species: a breath of life or death? Clin Cancer Res 13:789\u2013794","journal-title":"Clin Cancer Res"},{"key":"625_CR14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1034\/j.1600-0749.2001.140303.x","volume":"14","author":"FL Meyskens Jr","year":"2001","unstructured":"Meyskens FL Jr, Farmer P, Fruehauf JP (2001) Redox regulation in human melanocytes and melanoma. Pigment Cell Res 14:148\u2013154","journal-title":"Pigment Cell Res"},{"key":"625_CR15","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0891-5849(01)00650-5","volume":"31","author":"FL Meyskens Jr","year":"2001","unstructured":"Meyskens FL Jr, McNulty SE, Buckmeier JA et al (2001) Aberrant redox regulation in human metastatic melanoma cells compared to normal melanocytes. Free Radic Biol Med 31:799\u2013808","journal-title":"Free Radic Biol Med"},{"key":"625_CR16","first-page":"1197","volume":"5","author":"FL Meyskens Jr","year":"1999","unstructured":"Meyskens FL Jr, Buckmeier JA, McNulty SE, Tohidian NB (1999) Activation of nuclear factor-kappa B in human metastatic melanomacells and the effect of oxidative stress. Clin Cancer Res 5:1197\u20131202","journal-title":"Clin Cancer Res"},{"key":"625_CR17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0378-8741(00)00213-0","volume":"71","author":"P Scartezzini","year":"2000","unstructured":"Scartezzini P, Speroni E (2000) Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol 71:23\u201343","journal-title":"J Ethnopharmacol"},{"key":"625_CR18","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s10495-007-0129-x","volume":"12","author":"F Malik","year":"2007","unstructured":"Malik F, Kumar A, Bhushan S et al (2007) Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine. Apoptosis 12:2115\u20132133","journal-title":"Apoptosis"},{"key":"625_CR19","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1007\/s10495-008-0271-0","volume":"13","author":"C Mandal","year":"2008","unstructured":"Mandal C, Dutta A, Mallick A et al (2008) Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade. Apoptosis 13:1450\u20131464","journal-title":"Apoptosis"},{"key":"625_CR20","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1007\/s10495-008-0273-y","volume":"13","author":"JH Oh","year":"2008","unstructured":"Oh JH, Lee TJ, Kim SH et al (2008) Induction of apoptosis by withaferin A in human leukemia U937 cells through down-regulation of Akt phosphorylation. Apoptosis 13:1494\u20131504","journal-title":"Apoptosis"},{"key":"625_CR21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1158\/0008-5472.CAN-06-2430","volume":"67","author":"S Srinivasan","year":"2007","unstructured":"Srinivasan S, Ranga RS, Burikhanov R, Han SS, Chendil D (2007) Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells. Cancer Res 67:246\u2013253","journal-title":"Cancer Res"},{"key":"625_CR22","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1124\/mol.106.030015","volume":"71","author":"H Yang","year":"2007","unstructured":"Yang H, Shi G, Dou QP (2007) The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from \u201cIndian winter cherry\u201d. Mol Pharmacol 71:426\u2013437","journal-title":"Mol Pharmacol"},{"key":"625_CR23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/1535-7163.MCT-09-0771","volume":"9","author":"S Koduru","year":"2010","unstructured":"Koduru S, Kumar R, Srinivasan S, Evers MB, Damodaran C (2010) Notch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesis. Mol Cancer Ther 9:202\u2013210","journal-title":"Mol Cancer Ther"},{"key":"625_CR24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10456-004-1026-3","volume":"7","author":"R Mohan","year":"2004","unstructured":"Mohan R, Hammers HJ, Bargagna-Mohan P et al (2004) Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis 7:115\u2013122","journal-title":"Angiogenesis"},{"key":"625_CR25","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1158\/0008-5472.CAN-08-1510","volume":"68","author":"SD Stan","year":"2008","unstructured":"Stan SD, Hahm ER, Warin R, Singh SV (2008) Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo. Cancer Res 68:7661\u20137669","journal-title":"Cancer Res"},{"key":"625_CR26","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1074\/jbc.M606728200","volume":"282","author":"M Kaileh","year":"2007","unstructured":"Kaileh M, Vanden Berghe W, Heyerick A et al (2007) Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity. J Biol Chem 282:4253\u20134264","journal-title":"J Biol Chem"},{"key":"625_CR27","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bcp.2009.09.017","volume":"79","author":"Y Yu","year":"2010","unstructured":"Yu Y, Hamza A, Zhang T et al (2010) Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Biochem Pharmacol 79:542\u2013551","journal-title":"Biochem Pharmacol"},{"key":"625_CR28","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.freeradbiomed.2009.03.022","volume":"46","author":"TJ Lee","year":"2009","unstructured":"Lee TJ, Um HJ, Min do S, Park JW, Choi KS, Kwon TK (2009) Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Free Radic Biol Med 46:1639\u20131649","journal-title":"Free Radic Biol Med"},{"key":"625_CR29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.onc.1210638","volume":"27","author":"A Deniaud","year":"2008","unstructured":"Deniaud A, Sharaf el dein O, Maillier E et al (2008) Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis. Oncogene 27:285\u2013299","journal-title":"Oncogene"},{"key":"625_CR30","doi-asserted-by":"crossref","first-page":"e9924","DOI":"10.1371\/journal.pone.0009924","volume":"5","author":"N Buron","year":"2010","unstructured":"Buron N, Porceddu M, Brabant M et al (2010) Use of human cancer cell lines mitochondria to explore the mechanisms of BH3 peptides and ABT-737-induced mitochondrial membrane permeabilization. PLoS ONE 5:e9924","journal-title":"PLoS ONE"},{"key":"625_CR31","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.2741\/3470","volume":"14","author":"AS Belzacq-Casagrande","year":"2009","unstructured":"Belzacq-Casagrande AS, Martel C, Pertuiset C, Borgne-Sanchez A, Jacotot E, Brenner C (2009) Pharmacological screening and enzymatic assays for apoptosis. Front Biosci 14:3550\u20133562","journal-title":"Front Biosci"},{"key":"625_CR32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/sj.onc.1201182","volume":"15","author":"I Guenal","year":"1997","unstructured":"Guenal I, Sidoti-de Fraisse C, Gaumer S, Mignotte B (1997) Bcl-2 and Hsp27 act at different levels to suppress programmed cell death. Oncogene 15:347\u2013360","journal-title":"Oncogene"},{"key":"625_CR33","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0006-3495(99)77239-5","volume":"76","author":"V Petronilli","year":"1999","unstructured":"Petronilli V, Miotto G, Canton M et al (1999) Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys J 76:725\u2013734","journal-title":"Biophys J"},{"key":"625_CR34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(00)80434-1","volume":"91","author":"P Li","year":"1997","unstructured":"Li P, Nijhawan D, Budihardjo I et al (1997) Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479\u2013489","journal-title":"Cell"},{"key":"625_CR35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/10715769900300271","volume":"30","author":"MV Clement","year":"1999","unstructured":"Clement MV, Pervaiz S (1999) Reactive oxygen intermediates regulate cellular response to apoptotic stimuli: an hypothesis. Free Radic Res 30:247\u2013252","journal-title":"Free Radic Res"},{"key":"625_CR36","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.freeradbiomed.2009.12.022","volume":"48","author":"ML Circu","year":"2010","unstructured":"Circu ML, Aw TY (2010) Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48:749\u2013762","journal-title":"Free Radic Biol Med"},{"key":"625_CR37","doi-asserted-by":"crossref","first-page":"15038","DOI":"10.1073\/pnas.0601945103","volume":"103","author":"KM Robinson","year":"2006","unstructured":"Robinson KM, Janes MS, Pehar M et al (2006) Selective fluorescent imaging of superoxide in vivo using ethidium-based probes. Proc Natl Acad Sci USA 103:15038\u201315043","journal-title":"Proc Natl Acad Sci USA"},{"key":"625_CR38","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1074\/jbc.M004687200","volume":"276","author":"JL Hirpara","year":"2001","unstructured":"Hirpara JL, Clement MV, Pervaiz S (2001) Intracellular acidification triggered by mitochondrial-derived hydrogen peroxide is an effector mechanism for drug-induced apoptosis in tumor cells. J Biol Chem 276:514\u2013521","journal-title":"J Biol Chem"},{"key":"625_CR39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0070-2137(01)80007-8","volume":"36","author":"SM Deneke","year":"2000","unstructured":"Deneke SM (2000) Thiol-based antioxidants. Curr Top Cell Regul 36:151\u2013180","journal-title":"Curr Top Cell Regul"},{"key":"625_CR40","doi-asserted-by":"crossref","first-page":"36071","DOI":"10.1074\/jbc.M807061200","volume":"283","author":"R Franco","year":"2008","unstructured":"Franco R, DeHaven WI, Sifre MI, Bortner CD, Cidlowski JA (2008) Glutathione depletion and disruption of intracellular ionic homeostasis regulate lymphoid cell apoptosis. J Biol Chem 283:36071\u201336087","journal-title":"J Biol Chem"},{"key":"625_CR41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/abio.2000.4765","volume":"286","author":"H Kamencic","year":"2000","unstructured":"Kamencic H, Lyon A, Paterson PG, Juurlink BH (2000) Monochlorobimane fluorometric method to measure tissue glutathione. Anal Biochem 286:35\u201337","journal-title":"Anal Biochem"},{"key":"625_CR42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/092986707779941078","volume":"14","author":"CA La Porta","year":"2007","unstructured":"La Porta CA (2007) Drug resistance in melanoma: new perspectives. Curr Med Chem 14:387\u2013391","journal-title":"Curr Med Chem"},{"key":"625_CR43","first-page":"4171","volume":"56","author":"AH Dantzig","year":"1996","unstructured":"Dantzig AH, Shepard RL, Cao J et al (1996) Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979. Cancer Res 56:4171\u20134179","journal-title":"Cancer Res"},{"key":"625_CR44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00008390-199806000-00001","volume":"8","author":"E Selzer","year":"1998","unstructured":"Selzer E, Schlagbauer-Wadl H, Okamoto I, Pehamberger H, Potter R, Jansen B (1998) Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines. Melanoma Res 8:197\u2013203","journal-title":"Melanoma Res"},{"key":"625_CR45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","volume":"87","author":"K Bedard","year":"2007","unstructured":"Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87:245\u2013313","journal-title":"Physiol Rev"},{"key":"625_CR46","doi-asserted-by":"crossref","first-page":"44784","DOI":"10.1074\/jbc.M207217200","volume":"277","author":"J St-Pierre","year":"2002","unstructured":"St-Pierre J, Buckingham JA, Roebuck SJ, Brand MD (2002) Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem 277:44784\u201344790","journal-title":"J Biol Chem"},{"key":"625_CR47","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/15216540310001639652","volume":"55","author":"H Vieira","year":"2003","unstructured":"Vieira H, Kroemer G (2003) Mitochondria as targets of apoptosis regulation by nitric oxide. IUBMB Life 55:613\u2013616","journal-title":"IUBMB Life"},{"key":"625_CR48","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1586\/14737140.8.11.1751","volume":"8","author":"JP Fruehauf","year":"2008","unstructured":"Fruehauf JP, Trapp V (2008) Reactive oxygen species: an Achilles\u2019 heel of melanoma? Expert Rev Anticancer Ther 8:1751\u20131757","journal-title":"Expert Rev Anticancer Ther"},{"key":"625_CR49","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.freeradbiomed.2007.10.031","volume":"44","author":"B Marengo","year":"2008","unstructured":"Marengo B, De Ciucis C, Verzola D et al (2008) Mechanisms of BSO (L-buthionine-S,R-sulfoximine)-induced cytotoxic effects in neuroblastoma. Free Radic Biol Med 44:474\u2013482","journal-title":"Free Radic Biol Med"},{"key":"625_CR50","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1002\/eji.200424981","volume":"34","author":"P Gomez-Bougie","year":"2004","unstructured":"Gomez-Bougie P, Bataille R, Amiot M (2004) The imbalance between Bim and Mcl-1 expression controls the survival of human myeloma cells. Eur J Immunol 34:3156\u20133164","journal-title":"Eur J Immunol"},{"key":"625_CR51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-5793(02)02472-9","volume":"516","author":"M Raisova","year":"2002","unstructured":"Raisova M, Goltz G, Bektas M et al (2002) Bcl-2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes. FEBS Lett 516:47\u201352","journal-title":"FEBS Lett"},{"key":"625_CR52","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1200\/JCO.2006.06.0483","volume":"24","author":"AY Bedikian","year":"2006","unstructured":"Bedikian AY, Millward M, Pehamberger H et al (2006) Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group. J Clin Oncol 24:4738\u20134745","journal-title":"J Clin Oncol"},{"key":"625_CR53","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(00)03207-4","volume":"356","author":"B Jansen","year":"2000","unstructured":"Jansen B, Wacheck V, Heere-Ress E et al (2000) Chemosensitisation of malignant melanoma by BCL2 antisense therapy. Lancet 356:1728\u20131733","journal-title":"Lancet"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-011-0625-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10495-011-0625-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-011-0625-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T14:41:20Z","timestamp":1559140880000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-011-0625-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,28]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["625"],"URL":"https:\/\/doi.org\/10.1007\/s10495-011-0625-x","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,28]]}}}